surpass trial tirzepatide SURPASS-5: lowers HbA1c in adults with type 2 diabetes on insulin glargine New Dual Incretin Agonist for

Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Three peptides, BPC-157, Thymosin Beta-4 (TB4), and its synthetic fragment TB-500, have generated significant interest in orthopedic and sports medicine for their potential to accelerate healing in tendons, ligaments, muscle, and bone

What does the article call the biggest risk of relying on OTC GLP-1 products

Based on available research, researchers and regulators believe the risk is rare